Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine plus tandospirone for vascular depression with somatization symptoms
ChiCTR2100048442Phase 4Completed
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of venlafaxine and tandospirone in vascular depression (VD) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Psychological condition at Week 8 and Decrease rate of each scale score after treatment at Week 8. Started Jul 2021; status: completed.
02
Drugs
venlafaxinetandospirone
03
Conditions
vascular depression (VD)
Beyond the preview
Go deeper on ChiCTR2100048442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048442.